Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Alcon Inc (ALC)

Alcon Inc (ALC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,090,448
  • Shares Outstanding, K 490,087
  • Annual Sales, $ 8,291 M
  • Annual Income, $ 376,000 K
  • 60-Month Beta 0.78
  • Price/Sales 4.25
  • Price/Cash Flow 15.44
  • Price/Book 1.80
Trade ALC with:
  • Price/Earnings ttm 29.85
  • Earnings Per Share ttm 2.34
  • Most Recent Earnings 0.63 on 08/09/22
  • Next Earnings Date 08/16/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-3851 Ophthalmic Goods

    Medical Instruments

Options Overview Details

View History
  • Implied Volatility 24.85% ( -1.91%)
  • Historical Volatility 26.65%
  • IV Percentile 22%
  • IV Rank 26.65%
  • IV High 45.98% on 05/10/22
  • IV Low 17.17% on 09/02/21
  • Put/Call Vol Ratio 1.65
  • Today's Volume 979
  • Volume Avg (30-Day) 737
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 13,224
  • Open Int (30-Day) 9,836

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.57
  • Number of Estimates 4
  • High Estimate 0.59
  • Low Estimate 0.56
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +5.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.97 +1.59%
on 07/14/22
78.56 -10.81%
on 07/29/22
+0.16 (+0.23%)
since 07/12/22
3-Month
64.42 +8.77%
on 06/16/22
78.56 -10.81%
on 07/29/22
+1.20 (+1.74%)
since 05/12/22
52-Week
63.92 +9.62%
on 05/09/22
88.78 -21.07%
on 12/29/21
-0.59 (-0.83%)
since 08/12/21

Most Recent Stories

More News
Alcon (ALC) Q2 Earnings Surpass Estimates, Guidance Lowered

Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.

DGX : 140.55 (-0.01%)
ALC : 70.07 (+0.73%)
AMN : 114.23 (+0.77%)
ZBH : 117.22 (+1.93%)
Alcon Reports Second Quarter 2022 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2022. For the second quarter of 2022, sales were $2.2 billion, an increase...

ALC : 70.07 (+0.73%)
Cigna (CI) to Announce Q2 Earnings: Here's What to Expect

Cigna's (CI) second-quarter results are likely to reflect higher pharmacy revenues and a growing customer base.

CI : 290.92 (+1.72%)
ALC : 70.07 (+0.73%)
AKRO : 13.30 (+5.14%)
HIMS : 7.15 (+0.85%)
DraftKings (DKNG) to Report Q2 Earnings: What's in Store?

DraftKings' (DKNG) second-quarter 2022 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.

ALC : 70.07 (+0.73%)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
DKNG : 20.67 (+11.49%)
What Awaits Warner Bros. Discovery (WBD) in Q2 Earnings?

Warner Bros. Discovery's (WBD) Q2 results are expected to reflect benefits from a solid content portfolio and slow yet steady advertising revenues.

ALC : 70.07 (+0.73%)
WBD : 13.68 (unch)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
NortonLifeLock (NLOK) to Report Q1 Earnings: What's in Store?

Though the heightened IT security demand amid the hybrid work environment is likely to have benefited NortonLifeLock's (NLOK) Q1 performance, forex headwinds might have hurt sales and earnings growth.

ALC : 70.07 (+0.73%)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
NLOK : 24.19 (+0.58%)
CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?

Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.

ALC : 70.07 (+0.73%)
CVS : 106.39 (+2.05%)
ANIP : 37.47 (+5.88%)
ADPT : 12.32 (+1.65%)
Cumulus Media (CMLS) to Report Q2 Earnings: What's in Store?

Cumulus Media's (CMLS) Q2 performance is expected to have been aided by growth in digital business and demand for podcasting content amid tepid demand for advertising solutions.

ALC : 70.07 (+0.73%)
CMLS : 9.42 (+3.40%)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
Paramount Global (PARA) to Report Q2 Earnings: What's in Store?

Paramount Global's (PARA) Q2 performance is expected to have been aided by growth in viewership, driven by strength in streaming services, including Paramount+ amid tepid advertiser demand.

ALC : 70.07 (+0.73%)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
PARA : 26.19 (+1.51%)
Factors to Note Ahead of Atlassian's (TEAM) Q4 Earnings

Atlassian's (TEAM) Q4 results are likely to reflect the rising demand for cloud solutions and the massive digitalization of work by organizations.

ALC : 70.07 (+0.73%)
MRC : 10.07 (+0.60%)
GO : 40.51 (-2.64%)
TEAM : 283.25 (+2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma...

See More

Key Turning Points

3rd Resistance Point 71.64
2nd Resistance Point 70.91
1st Resistance Point 70.49
Last Price 70.07
1st Support Level 69.34
2nd Support Level 68.61
3rd Support Level 68.19

See More

52-Week High 88.78
Fibonacci 61.8% 79.28
Fibonacci 50% 76.35
Fibonacci 38.2% 73.42
Last Price 70.07
52-Week Low 63.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar